Simulations Plus/$SLP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Simulations Plus
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Ticker
$SLP
Sector
Primary listing
Employees
213
Headquarters
Website
Simulations Plus Metrics
BasicAdvanced
$251M
-
-$3.20
1.09
-
Price and volume
Market cap
$251M
Beta
1.09
52-week high
$36.45
52-week low
$11.16
Average daily volume
347K
Financial strength
Current ratio
5.623
Quick ratio
5.227
Long term debt to equity
0.297
Total debt to equity
0.438
Profitability
EBITDA (TTM)
12.703
Gross margin (TTM)
59.60%
Net profit margin (TTM)
-81.66%
Operating margin (TTM)
9.89%
Effective tax rate (TTM)
6.45%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
2.79%
Return on equity (TTM)
-41.21%
Valuation
Price to revenue (TTM)
3.181
Price to book
1.97
Price to tangible book (TTM)
4.59
Price to free cash flow (TTM)
12.563
Free cash flow yield (TTM)
7.96%
Free cash flow per share (TTM)
0.99
Growth
Revenue change (TTM)
5.69%
Earnings per share change (TTM)
-898.95%
3-year revenue growth (CAGR)
13.75%
10-year revenue growth (CAGR)
15.23%
3-year earnings per share growth (CAGR)
84.41%
10-year earnings per share growth (CAGR)
28.52%
What the Analysts think about Simulations Plus
Analyst ratings (Buy, Hold, Sell) for Simulations Plus stock.
Simulations Plus Financial Performance
Revenues and expenses
Simulations Plus Earnings Performance
Company profitability
Simulations Plus News
AllArticlesVideos
ROSEN, A LONGSTANDING FIRM, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
Newsfile Corp·1 month ago
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
Business Wire·1 month ago
ROSEN, A TOP-RANKED LAW FIRM, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
Newsfile Corp·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Simulations Plus stock?
Simulations Plus (SLP) has a market cap of $251M as of March 14, 2026.
What is the P/E ratio for Simulations Plus stock?
The price to earnings (P/E) ratio for Simulations Plus (SLP) stock is 0 as of March 14, 2026.
Does Simulations Plus stock pay dividends?
No, Simulations Plus (SLP) stock does not pay dividends to its shareholders as of March 14, 2026.
When is the next Simulations Plus dividend payment date?
Simulations Plus (SLP) stock does not pay dividends to its shareholders.
What is the beta indicator for Simulations Plus?
Simulations Plus (SLP) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.